LIPID BLEND NANOCARRIER SCAFFOLD FOR ORAL BIOAVAILABILITY ENHANCEMENT OF EXEMESTANE
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: SINGH, Archu (Jamia Hamdard, Jamia Hamdard, India)
- Co-author(s): Archu Singh: Pharmaceutics, Jamia Hamdard, New Delhi, India
Kanchan Kohli: Pharmaceutics, Jamia Hamdard, New Delhi, India
Exemestane (EXE) is a novel oral steroidal aromatase inhibitor, approved for the treatment of breast cancer. However, its oral clinical application is limited because of low aqueous solubility and low oral bioavailability.
EXE loaded NLCs were using Precirol® ATO5 and Flaxseed as the solid lipid and liquid lipid respectively by.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.